1. Home
  2. STAA vs OBDE Comparison

STAA vs OBDE Comparison

Compare STAA & OBDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • OBDE
  • Stock Information
  • Founded
  • STAA 1982
  • OBDE 2020
  • Country
  • STAA United States
  • OBDE United States
  • Employees
  • STAA N/A
  • OBDE N/A
  • Industry
  • STAA Ophthalmic Goods
  • OBDE
  • Sector
  • STAA Health Care
  • OBDE
  • Exchange
  • STAA Nasdaq
  • OBDE NYSE
  • Market Cap
  • STAA 2.0B
  • OBDE 1.8B
  • IPO Year
  • STAA N/A
  • OBDE N/A
  • Fundamental
  • Price
  • STAA $30.20
  • OBDE $14.55
  • Analyst Decision
  • STAA Buy
  • OBDE Buy
  • Analyst Count
  • STAA 7
  • OBDE 1
  • Target Price
  • STAA $45.00
  • OBDE $16.00
  • AVG Volume (30 Days)
  • STAA 605.4K
  • OBDE 180.0K
  • Earning Date
  • STAA 10-30-2024
  • OBDE 11-06-2024
  • Dividend Yield
  • STAA N/A
  • OBDE 4.03%
  • EPS Growth
  • STAA N/A
  • OBDE N/A
  • EPS
  • STAA 0.33
  • OBDE N/A
  • Revenue
  • STAA $332,942,000.00
  • OBDE N/A
  • Revenue This Year
  • STAA $8.76
  • OBDE N/A
  • Revenue Next Year
  • STAA $14.28
  • OBDE N/A
  • P/E Ratio
  • STAA $91.84
  • OBDE N/A
  • Revenue Growth
  • STAA 8.83
  • OBDE N/A
  • 52 Week Low
  • STAA $26.66
  • OBDE $13.60
  • 52 Week High
  • STAA $52.68
  • OBDE $16.80
  • Technical
  • Relative Strength Index (RSI)
  • STAA 41.25
  • OBDE 55.89
  • Support Level
  • STAA $29.91
  • OBDE $14.16
  • Resistance Level
  • STAA $31.41
  • OBDE $14.65
  • Average True Range (ATR)
  • STAA 1.07
  • OBDE 0.20
  • MACD
  • STAA -0.08
  • OBDE 0.01
  • Stochastic Oscillator
  • STAA 15.56
  • OBDE 80.33

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About OBDE BLUE OWL CAPITAL CORP III

Blue Owl Capital Corp III is focused on originating and making loans to, and debt and equity investments in middle-market companies based predominantly in the United States. Its objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The company invests in senior secured or unsecured loans, subordinated loans or mezzanine loans and, to a lesser extent, equity and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company's common equity.

Share on Social Networks: